 Home > Medical News > Latest Medical News > Roche's PD-L1 antibody Tecentriq in the Phase 3 clinical trial of NSCLC patients reached the primary endpoint

Roche's PD-L1 antibody Tecentriq in the Phase 3 clinical trial of NSCLC patients reached the primary endpoint

 Last Update: 2021-04-27
 Source: Internet
 Author: User

Tags

procaine people search

trade show

Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

On March 22, Genentech, a subsidiary of Roche, announced that its PD-L1 antibody Tecentriq (atezolizumab, atelizumab) will be used for the treatment of early stage non-small cell lung cancer (NSCLC) patients in Phase 3 clinical trials.

Lung cancer is one of the leading causes of cancer deaths in the world, and NSCLC accounts for 80-85% of all lung cancers.

Tecentriq is an anti-PD-L1 monoclonal antibody that binds to the PD-L1 protein on the surface of tumor cells and tumor infiltrating immune cells.

In a randomized, multi-center, open-label phase 3 clinical study named IMpower010, NSCLC patients in stage IB-IIIA were surgically removed and treated with cisplatin, and then randomly received Tecentriq or the best supportive treatment.

Note: The original text has been deleted

Reference materials:

[1] Pivotal Phase III Study Shows Genentech's TecentriqHelped People With Early Lung Cancer Live Longer Without Their DiseaseReturning.

This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

Related Products

L-Ascorbate-2-Monophosphate Feed Grade

CAS No.: 109620-90-8

Feed Grade

Potassium Sorbate from reliable manufacturer

CAS No.: 590-00-1

Food Grade

Doxycycline Hydrochloride

CAS No.: 10592-13-9

Pharmaceutical Grade

Hot Tags

united states jobs(223)

jobs united states(236)

1 year treasury(277)

1 year subscription(296)

single use technology(195)

announcements today(81)

ups united states(221)

united states logo(227)

80 20 company(94)

healthy food name(42)

Hot Articles

The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.